Mallika Ann Ambat, Actelion Pharmaceuticals
Mallika Ann Ambat, Senior Director, Market Research, Actelion Pharmaceuticals
Mallika Ann Ambat is the Director, US Market Research Lead at Actelion. She has over twenty years of hands-on pharmaceutical and bio-tech experience.
She started her career at Pharma companies such as Hoffman-La Roche and Schering-Plough on the East Coast, and most recently worked at bio-tech companies, including Agouron-Pfizer (formerly in San Diego) and Actelion in the Bay Area.
She has extensive market research experience with key stakeholders (HCPs, patients and payors) and has worked in both primary care and specialty markets. At Actelion, she works in Pulmonary Arterial Hypertension, MF-CTCL and Gaucher’s Disease.
In her role at Actelion, she collaborates closely with her sales analytic colleagues to optimize decisions for business development, portfolio planning and new product commercialization.
Mallika earned an MBA degree from St. Joseph’s University in Philadelphia and has a B.S. in Life Sciences.
Meghna Chowdary, Relypsa, Inc.
Meghna Chowdary, Executive Director, Strategic Insights and Analytics, Relypsa, Inc.
Meghna leads Strategic Insights and Analytics at Relypsa. In her role, she serves as a strategic advisor to executive leadership, providing insights on product performance and contributing to portfolio planning. She was previously at Genentech for 10 years, where her last role was leading the Market Planning group supporting the Oncology business unit. The group was responsible for driving strategic planning efforts for 13 in-line products and late-stage molecules. Prior to Genentech, she worked at a boutique hospital strategic planning firm that assessed how new technologies would change the delivery of healthcare services. She holds a BS in Biology from Stanford and an MBA from Wharton.
Michael Gerhold, Neurocrine Biosciences
Michael Gerhold, Head of Commercial Analytics, Neurocrine Biosciences
Michael is the Head of Commercial Analytics at Neurocrine Biosciences. In his role, Michael oversees a team that provides market research and analytics support for newly launched INGREZZA as well as life cycle management opportunities.
Prior to joining Neurocrine Biosciences, Michael was at Otsuka Pharmaceuticals where he provided market research insights to the successful HCP and DTC launch of Rexulti, a novel antipsychotic. Michael has over 15 years of experience working in a variety of roles in market research, marketing, analytics and forecasting supporting in-line brand teams, life cycle management, and business development.
Michael holds a MBA and Master of Science in Biomedical Engineering from Purdue University and a BS in Biophysics from University of California San Diego. Michael is originally from San Diego, California.
Sharon Grehan, Gilead Sciences
Sharon Grehan, Ph.D., Executive Director, Marketing Sciences, Gilead Sciences
Rahim Hirji, Omeros Corporation
Rahim Hirji, Director, Marketing and New Product Planning, Omeros Corporation
Carly Loeb, Dermira
Carly Loeb, Ph.D., Sr. Director, Market Insights & Operations, Dermira
Ruchi Varshneya, Abbott
Ruchi Varshneya, Senior Director, Corporate Marketing, Abbott
Ruchi is Senior Director of Global Market Insights and Strategy at Abbott Diabetes Care based in Alameda, California. In her current role she is responsible for driving insights based product innovation and
strategic planning. Ruchi has led Insights function and teams in diverse industries including Consumer packaged goods, Application Software, Pharmaceutical and Medical Devices.
She has a reputation of being an authentic voice of the customer. She is regarded as an inspiring and collaborative leader who is respected for setting high goals for her team and consistently delivering on
She earned her engineering degree from India Institute of Technology, India; an MBA from XLRI school of management, India and a Master’s in Public Health from Johns Hopkins University.
Ruchi is passionate about volunteering in her local community and for a variety of causes in India.